Cite

HARVARD Citation

    Kuhlen, M. et al. (2017). Neurotoxic side effects in children with refractory or relapsed T‐cell malignancies treated with nelarabine based therapy. British journal of haematology. pp. 272-283. [Online]. 
  
Back to record